Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Acta Haematologica Polonica|January 1, 1995
[T lymphocytes from patients with Hodgkin's disease suppress erythroid progenitor growth from autologous marrow]J Hansz, M Kozłowska-Skrzypczak, K Sawiński, et al.
Acta Haematologica Polonica|January 1, 1995
Activated lymphocytes in the marrow cell suspension decrease the mafosfamide-induced CFU-GM cytotoxicityT Woźny, K Sawiński, M Kozłowska-Skrzypczak, et al.
Acta Haematologica Polonica|January 1, 1994
[Treatment outcome of advanced Hodgkin's disease based on using an alternating program ChLVPP (chlorambucil, vinblastine, procarbazine, prednisone) and ABV (doxorubicin, bleomycin, vinblastine)]M Komarnicki, A Balcerzak, P Górski, et al.
Acta Haematologica Polonica|January 1, 1976
[Tissue migration of neutrophil granulocytes in the course of antiproliferative treatment in Hodgkin's disease]H Wysocki, B Wierusz-Wysocka, B Prazmowska-Owczarek, et al.
Acta Haematologica Polonica|January 1, 1990
[Neutrophils do not affect clonal growth of granulocyte progenitor cells cultured in vivo in diffuse chambers]J Hansz, T Wozny, J Jurkowiecka, et al.
Leukemia|May 17, 2003
Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioningP Dreger, R Brand, J Hansz, et al.
European Journal of Haematology|January 26, 1999
2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in PolandT Robak, M Błasińska-Morawiec, J Błoński, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 1998
The effect of 2-h infusion of 2-chlorodeoxyadenosine (cladribine) with prednisone in previously untreated B-cell chronic lymphocytic leukaemiaT Robak, M Błasińska-Morawiec, J Z Błoński, et al.
Bone Marrow Transplantation|April 20, 2004
Treatment for primary refractory Hodgkin's disease: a comparison of high-dose chemotherapy followed by ASCT with conventional therapyJ Czyz, R Szydlo, W Knopinska-Posluszny, et al.
Leukemia & Lymphoma|June 1, 1996
2-chlorodeoxyadenosine (2-CdA) in 2-hour versus 24-hour intravenous infusion in the treatment of patients with hairy cell leukemiaT Robak, M Błasińska-Morawiec, E Krykowski, et al.
Pageof 6